| Literature DB >> 30483444 |
Jiancheng Liu1, Hong Sun2, Cunxi Nie1, Wenxia Ge1, Yongqiang Wang1, Wenju Zhang1.
Abstract
In this study, the immunomodulatory activity of oligopeptide (CP) derived from solid-state fermented cottonseed meal were investigated in immunosuppressed BALB/c mice models by treatment with cyclophosphamide (CY). Results indicated that oligopeptide increased the thymus and spleen indices of CY-treated mice. The count of plague forming cells (PFC) and the content of half serum hemolysis (HC50) in immunosuppressive mice were restored to the normal level in CP-10 and CP-20 groups while the cytokines interleukin (IL)-2, IL-6, and tumor necrosis factor alpha (TNF-α) were increased significantly in CP-20 group. Similar increasing the immunoglobulin of IgG and IgM content in the serum of CP-10 group were also observed. These findings indicated that oligopeptide derived from solid-state fermented cottonseed meal had a strong immune-enhancing activity as well as a protective effect against immunosuppression induced by cyclophosphamide in mice.Entities:
Keywords: Cottonseed meal; Cyclophosphamide; Immunomodulatory; Oligopeptide; Solid-state fermentation
Year: 2018 PMID: 30483444 PMCID: PMC6233401 DOI: 10.1007/s10068-018-0414-1
Source DB: PubMed Journal: Food Sci Biotechnol ISSN: 1226-7708 Impact factor: 2.391
Average oligopeptide yield and composition of cottonseed meal and cottonseed meal oligopeptide
| Compositions | Cottonseed meal (%) | Cottonseed meal oligopeptide (%) |
|---|---|---|
| Oligopeptide yield | 2.78 ± 0.21 | 24.4 ± 1.28a |
| Protein | 46.33 ± 0.15 | 90.56 ± 0.18 |
| Fiber | 10.37 ± 0.31 | ND |
| Fat | 0.46 ± 0.08 | ND |
| Ash | 6.58 ± 0.03 | 1.27 ± 0.06 |
| Free gossypol | 634.01 ± 19.90 | ND |
| Reducing sugar | 0.40 ± 0.06 | 3.14 ± 0.09 |
ND not detected
aThis refers to the production of oligopeptide in the fermentation of cottonseed meal
Fig. 1Molecular weight distribution of oligopeptide derived from solid-fermented cottonseed meal. x-axis, elution volume (mL); y-axis, response value (mAU)
Composition of total amino acid in cottonseed meal oligopeptide
| Amino acids | Content (%) |
|---|---|
| Aspartic acid | 8.14 ± 0.12 |
| Threonine | 1.73 ± 0.03 |
| Serine | 2.66 ± 0.06 |
| Glutamic acid | 25.84 ± 0.54 |
| Glycine | 2.73 ± 0.07 |
| Alanine | 2.18 ± 0.04 |
| Cysteine | 2.29 ± 0.06 |
| Valine | 3.73 ± 0.10 |
| Methionine | 0.81 ± 0.01 |
| Isoleucine | 1.60 ± 0.02 |
| Leucine | 3.51 ± 0.11 |
| Tyrosine | 2.99 ± 0.03 |
| Phenylalanine | 5.65 ± 0.09 |
| Lysine | 2.50 ± 0.06 |
| Histidine | 1.19 ± 0.02 |
| Arginine | 7.09 ± 0.18 |
| Proline | 3.28 ± 0.05 |
| Total amino acids | 77.92 ± 0.81 |
| AAA | 33.98 ± 0.33 |
| BAA | 10.78 ± 0.14 |
AAA acidic amino acid (e.g., glutamic acid and aspartic acid), BAA basic amino acid (e.g., arginine, histidine, and lysine)
Effects of oligopeptide on the mouse spleen and thymus indices in cyclophosphamide-treated mice
| Group | Thymus index (mg/g) | Spleen index (mg/g) |
|---|---|---|
| NC | 1.95 ± 0.16a | 8.17 ± 0.87a |
| CY | 1.28 ± 0.15b | 5.54 ± 0.10b |
| CP-5 | 1.60 ± 0.25a | 7.32 ± 0.91a |
| CP-10 | 1.99 ± 0.20a | 9.25 ± 0.11a |
| CP-20 | 1.85 ± 0.19a | 8.57 ± 1.43a |
Different characters in each column indicate significantly different at 0.05 levels
NC normal control, CY cyclophosphamide model control, CP cottonseed meal oligopeptides were administered via gavage in mice by cyclophosphamide treated
Effects of oligopeptide on the PFC and HC50 in cyclophosphamide-treated mice
| Group | PFC | HC50 |
|---|---|---|
| NC | 0.36 ± 0.01a | 7.65 ± 0.39a |
| CY | 0.28 ± 0.04b | 5.38 ± 0.49b |
| CP-5 | 0.37 ± 0.01a | 6.77 ± 0.45b |
| CP-10 | 0.40 ± 0.02a | 7.97 ± 0.20a |
| CP-20 | 0.39 ± 0.02a | 7.84 ± 0.41a |
Different characters in each column indicate significantly different at 0.05 levels
NC normal control, CY cyclophosphamide model control, CP cottonseed meal oligopeptides were administered via gavage in mice by cyclophosphamide treated, PFC plague forming cell, HC50 half hemolytic value
Effects of oligopeptide on serum IL-2, IL-6, TNF-α, IgG, and IgM in cyclophosphamide-treated mice
| Group | IL-2 (pg/mL) | IL-6 (pg/mL) | TNF-α (ng/L) | IgG (µg/mL) | IgM (µg/mL) |
|---|---|---|---|---|---|
| NC | 1739 ± 22.3a | 79.74 ± 2.78a | 595.7 ± 23.9a | 382.9 ± 27.9a | 50.93 ± 2.00a |
| CY | 1653 ± 41.0b | 69.46 ± 2.68b | 564.5 ± 20.8a | 317.4 ± 21.5b | 32.32 ± 3.67b |
| CP-5 | 2101 ± 17.4a | 72.25 ± 4.03b | 589.5 ± 10.6a | 337.8 ± 10.1a | 35.20 ± 1.97b |
| CP-10 | 2106 ± 18.1a | 84.56 ± 4.80a | 600.0 ± 37.9a | 439.1 ± 42.9c | 52.53 ± 2.9a |
| CP-20 | 2047 ± 10.0a | 82.53 ± 5.92a | 685.8 ± 56.8b | 396.9 ± 16.3ac | 43.56 ± 1.64a |
Different characters in each column indicate significantly different at 0.05 levels
NC normal control, CY cyclophosphamide model control, CP cottonseed meal oligopeptides were administered via gavage in mice by cyclophosphamide treated